Ligand · MI5
MI5 · N-(3-methylisothiazol-5-yl)-3-(1-methyl-1H-pyrazol-4-yl)-5-[(3R)-piperidin-3-yl]pyrazolo[1,5-a]pyrimidin-7-amine
MI5, N-(3-methylisothiazol-5-yl)-3-(1-methyl-1H-pyrazol-4-yl)-5-[(3R)-piperidin-3-yl]pyrazolo[1,5-a]pyrimidin-7-amine (C19 H22 N8 S, 394.5 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1 PDB entry). Every binding site…
- Component
- MI5
- Formula
- C19 H22 N8 S
- Class
- ligand
- Structures
- 2
- PDB entries
- 1
Binding sites
MI5 in 2 structures; the first of them:
- 3OT8 · X-ray crystal structure of compound 17r bound to human Chk1 kinase domain · MI5 A1 · binds LEU15, GLY16, GLU17, VAL23, ALA36, LYS38, VAL68, LEU84 and 10 more
- 3OT8 · X-ray crystal structure of compound 17R bound to human CHK1 kinase domain · MI5 A1 · binds LEU15, GLY16, GLU17, VAL23, ALA36, LYS38, VAL68, LEU84 and 10 more
Residues it binds most
GLU 2, LEU 2, GLY 2, SER 2, VAL 2, ALA 2, ASP 2, CYS 2, LYS 2, TYR 2 (residue and the binding sites it lines).
Found with
- GOL · Glycerol
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.